“In addition to now having the ability to immediately mass...

“In addition to now having the ability to immediately mass produce the Canntab and Pharmocann medical Cannabis products, together, we are about to produce high volume co-branded nutraceutical products under the Bio Health Pharmaceuticals and VitaHemp banners, initially targeting mature Hemp markets in Hong Kong, Japan & Korea. There are positive opportunities for both companies in existing markets, whilst exploring new, particularly large Asian chemist and health food conglomerates, including in the massive Chinese markets.”

WE FINALLY HAVE AN ANSWER ON CANNTAB!!!!
rather than wait for Canntab to finally get an export license we are now producing it for the Asian market.